Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026Advanced ScienceOpen Access

WTAP‐Mediated m 6 A Modification Targets the LRP1‐Lipid Metabolism Axis to Regulate Joint Cartilage Regeneration

View Full Paper
Ask AI
Bookmark
Share

Authors

CHChenyan HuangCDChenyu DengZGZ Gao

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates targeted m6A modification improves cartilage regeneration, suggesting therapeutic potential for joint injuries.

Key Points

  • The aim is to explore how WTAP-mediated m6A modification affects cartilage regeneration through the LRP1-lipid metabolism pathway.
  • Investigated the role of WTAP in m6A modifications related to cartilage
  • Analyzed the impact on lipid metabolism and its correlation with chondrogenesis
  • Assessed therapeutic implications for joint cartilage regeneration
  • m6A modification significantly enhanced chondrogenesis under specific conditions
  • Alterations in lipid metabolism pathways were directly linked to improved cartilage regeneration
  • Suggests that targeting this pathway may provide new therapeutic strategies for joint regeneration

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/69fd7eb0bfa21ec5bbf06fabhttps://doi.org/10.1002/advs.75479
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ACSL4‐Dependent Lysosomal Lipid Peroxidation Links WTAP‐Mediated m 6 A Modification to Intervertebral Disc Degeneration2026
  2. 2Dual-modal antioxidant and epigenetic synergy attenuates the self-perpetuating senescence cycle in osteoarthritis2026
  3. 3The TRAF6/SPP1 axis participates in osteoarthritis progression through regulating the catabolism and anabolism of cartilage matrix2026
  4. 4METTL3 regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m6A-YTHDF2-dependent manner2024 · 6 citations
  5. 5Lactucopicrin promotes the autophagic degradation of MAP2K4/MKK4 by mediating CCDC50 palmitoylation to alleviate osteoarthritis progression2026 · 2 citations